John Gallon

16PUBLICATIONS
82CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Chemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 21, 2026
Beyond Circulating Tumor DNA for Efficacy: Can We Use Cell-Free DNA to Detect and Monitor Toxicity Signals?

|Jan 13, 2026
Probing intratumoral metabolic compartmentalisation in a patient with fumarate hydratase-deficient renal cancer using clinical hyperpolarised 13C-MRI and mass spectrometry imaging.

Ines Horvat-Menih, Ruth Casey, James Denholm

|Dec 24, 2025
Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug discovery.

John Hellgren, Bhavik Chouhan, Aydar Uatay

|Feb 07, 2023
DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations.

John Gallon, Antonio Rodriguez-Calero, Andrej Benjak

|Feb 01, 2023
PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition.

Joanna Triscott, Matthias Reist, Lukas Küng

|Jul 09, 2022
The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples.

Simon Stücheli, Selene Araya, Caner Ercan

Pageof 3

Frequent Collaborators

12 joint publications

Salvatore Piscuoglio

8 joint publications

Charlotte K Y Ng

6 joint publications

Caner Ercan

4 joint publications

Mark A Rubin